AR114808A1 - ANTI-a-SINUCLEIN ANTIBODIES - Google Patents

ANTI-a-SINUCLEIN ANTIBODIES

Info

Publication number
AR114808A1
AR114808A1 ARP180103658A ARP180103658A AR114808A1 AR 114808 A1 AR114808 A1 AR 114808A1 AR P180103658 A ARP180103658 A AR P180103658A AR P180103658 A ARP180103658 A AR P180103658A AR 114808 A1 AR114808 A1 AR 114808A1
Authority
AR
Argentina
Prior art keywords
antibodies
synuclein
sinuclein
synucleinopathies
fibrils
Prior art date
Application number
ARP180103658A
Other languages
Spanish (es)
Inventor
Terence Seward Baker
Peter Elliott
David James Mmillan
Daniel John Lightwood
Lichtervelde Lorenzo De
Marco Kriek
Kerry Louise Tyson
Patrick Downey
Original Assignee
Ucb Biopharma Sprl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb Biopharma Sprl filed Critical Ucb Biopharma Sprl
Priority to ARP180103658A priority Critical patent/AR114808A1/en
Publication of AR114808A1 publication Critical patent/AR114808A1/en

Links

Abstract

La presente se refiere a anticuerpos que se unen a a-sinucleína y a sus fragmentos capaces de unirse a a-sinucleína como monómero y en fibrillas y a la prevención de la agregación de a-sinucleína inducida por fibrillas de a-sinucleína. Los anticuerpos de la presente son para usar en el tratamiento de a-sinucleinopatías, incluida la enfermedad de Parkinson.This refers to antibodies that bind α-synuclein and fragments thereof capable of binding α-synuclein as monomer and in fibrils and the prevention of α-synuclein fibril-induced aggregation of α-synuclein. The antibodies herein are for use in the treatment of α-synucleinopathies, including Parkinson's disease.

ARP180103658A 2018-12-14 2018-12-14 ANTI-a-SINUCLEIN ANTIBODIES AR114808A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ARP180103658A AR114808A1 (en) 2018-12-14 2018-12-14 ANTI-a-SINUCLEIN ANTIBODIES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ARP180103658A AR114808A1 (en) 2018-12-14 2018-12-14 ANTI-a-SINUCLEIN ANTIBODIES

Publications (1)

Publication Number Publication Date
AR114808A1 true AR114808A1 (en) 2020-10-21

Family

ID=73042408

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP180103658A AR114808A1 (en) 2018-12-14 2018-12-14 ANTI-a-SINUCLEIN ANTIBODIES

Country Status (1)

Country Link
AR (1) AR114808A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11142570B2 (en) 2017-02-17 2021-10-12 Bristol-Myers Squibb Company Antibodies to alpha-synuclein and uses thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11142570B2 (en) 2017-02-17 2021-10-12 Bristol-Myers Squibb Company Antibodies to alpha-synuclein and uses thereof
US11827695B2 (en) 2017-02-17 2023-11-28 Bristol-Myers Squibb Company Antibodies to alpha-synuclein and uses thereof

Similar Documents

Publication Publication Date Title
CL2020001607A1 (en) Anti alpha-synuclein antibodies.
CL2020001637A1 (en) Antibodies to lilrb2
CO2017003048A2 (en) T-cell activating bispecific antigen-binding molecules that bind to cd3 and folate receptor 1 (folr1)
CL2021001506A1 (en) Antibodies that bind to cd3
CL2019003636A1 (en) Aadc polynucleotides for the treatment of parkinson's disease.
CL2018001175A1 (en) Anti-il1rap antibodies, binding molecules of biospecific antigens that bind il1rap and cd3 and their uses.
CL2017000515A1 (en) Cd123 linking agents and their use
ECSP20039623A (en) ANTI-ALPHA-SINUCLEIN ANTIBODIES
AR107442A1 (en) ANTIBODIES AGAINST THE ORPHANE RECEPTOR SIMILAR TO THE THIROSINE QUINASE 1 (ANTI-ROR1) RECEPTOR, BISPECIFIC ANTIBODIES THAT JOIN ROR1 AND THE CD3 ANTIGEN, AND METHODS FOR TREATMENT OF CANCER
UY36859A (en) ANTI-BCMA ANTIBODIES, MOLECULES OF UNION TO BIESPECTIFIC ANTIGENS THAT JOIN BCMA AND CD3, AND USES OF THESE
CO2017002719A2 (en) Anti-glucagon antibodies
ECSP16081503A (en) ANTIBODY MOLECULES THAT BIND AND USES LAG-3
CO2019003047A2 (en) Anti-il-33 antibodies and uses thereof
AR102657A1 (en) COMPOSITION TO TREAT FABRICS
CL2021001366A1 (en) Humanized antibodies against c-kit
UY38391A (en) ANTI-HLA-G ANTIBODIES, COMPOSITIONS INCLUDING ANTI-HLA-G ANTIBODIES AND METHODS OF USE OF ANTI HLA-G
UY36905A (en) POLIOMAVIRUS NEUTRALIZING ANTIBODIES
CL2021000909A1 (en) Stabilizing Trem2 Antibodies
CR20190417A (en) Anti-par2 antibodies and uses thereof
AR102658A1 (en) COMPOSITION FOR FABRIC TREATMENT
CO2017000346A2 (en) Aβ protofibril binding antibodies
PE20170258A1 (en) ANTIBODIES THAT BIND THE HUMAN CANNABINOID RECEPTOR 1 (CB1)
CO2017001087A2 (en) Anti angiopoietin-like protein 4 antibodies
CO2020001981A2 (en) Proteins that bind to nkg2d, cd16, and flt3
CL2019002735A1 (en) Antibodies that bind to steap-1.